Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellulose Sulfate Gel for HIV Prevention in Nigeria
NCT00120770Phase 3Terminated
- Sponsor
- FHI 360
- Start
- Nov 2004
- Modality
- Polysaccharide
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Cellulose Sulfate Gel with Placebo Gel (2 arms). Primary endpoint: Incidence of HIV-1 and HIV-2 infection. Started Nov 2004; status: terminated.
02
Drugs
cellulose sulfate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00120770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120770.